Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Research finds disparities in receiving recommended treatment for lung cancer

Research finds disparities in receiving recommended treatment for lung cancer

Disrupting key immune regulator boosts anti-tumor immunity, enables cancer clearance

Disrupting key immune regulator boosts anti-tumor immunity, enables cancer clearance

Dartmouth scientist awarded grant to build new AI technologies for lung cancer management

Dartmouth scientist awarded grant to build new AI technologies for lung cancer management

CRISPR helps find difficult to detect cancer cells

CRISPR helps find difficult to detect cancer cells

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

New algorithm hand-picks which cancer mutations are promising targets for immunotherapy

New algorithm hand-picks which cancer mutations are promising targets for immunotherapy

Lung cancer may soon be picked up by a blood test

Lung cancer may soon be picked up by a blood test

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Reactivating ‘tumor suppressor’ genes could offer new therapeutic approach for cancer

Reactivating ‘tumor suppressor’ genes could offer new therapeutic approach for cancer

Pembrolizumab provides added benefit for subpopulations of patients with metastatic NSCLC

Pembrolizumab provides added benefit for subpopulations of patients with metastatic NSCLC

Scientists identify pathway for treatment-resistant lung cancer

Scientists identify pathway for treatment-resistant lung cancer

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

New drug combination shows promise for treating non-small cell lung cancer patients

New drug combination shows promise for treating non-small cell lung cancer patients

Dacomitinib treatment for lung cancer increases overall survival but has more side effects

Dacomitinib treatment for lung cancer increases overall survival but has more side effects